Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Clinical trial NCT06155383 · RECRUITING
Trial details
- NCT number
- NCT06155383
- Sponsor
- RemeGen Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2025-01-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.